• Register
  • Login
  • Subscribe
  • Contact Us

Delivery of a Reimbursed Form of Bevacizumab 100 Mg/ 4 Ml and 400 Mg/ 16 Ml for Intravenous Use

BelgiumTenders notice for Delivery of a Reimbursed Form of Bevacizumab 100 Mg/ 4 Ml and 400 Mg/ 16 Ml for Intravenous Use. The reference ID of the tender is 127430734 and it is closing on 03 Nov 2025.

Tender Details

  • Country: Belgium
  • Summary: Delivery of a Reimbursed Form of Bevacizumab 100 Mg/ 4 Ml and 400 Mg/ 16 Ml for Intravenous Use
  • BET Ref No: 127430734
  • Deadline: 03 Nov 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: EUR 2943059.32
  • Notice Type: Tender
  • Document Ref. No.: 645977-2025
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Object of these deliveries: delivering a reimbursed form of Bevacizumab 100 mg/ 4 ml and 400 mg/ 16 ml for intravenous use.
    that the tenderer will make approximately 21 % of the estimated annual consumption available as a medical sample annually by request from the doctors To administer the product outside of reimbursable indications (cf. in accordance with the Royal Decree of 11 January 1993 establishing the conditions under which medicines for human use in the form of samples may be handed over).
    400 mg/ 16 ml for intravenous use
    Intravenous use.
    order Asking the doctors to administer the product outside of reimbursable indications (cf. in accordance with the Royal Decree of 11 January 1993 establishing the conditions under which medicines for human use in the form of samples may be handed over).
    Form of Bevacizumab 100 mg/ 4 ml and 400 mg/ 16 ml for intravenous use
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Delivery of a Reimbursed Form of Bevacizumab 100 Mg/ 4 Ml and 400 Mg/ 16 Ml for Intravenous Use - Belgium Tender

The UZ LEUVEN, a Government sector organization in Belgium, has announced a new tender for Delivery of a Reimbursed Form of Bevacizumab 100 Mg/ 4 Ml and 400 Mg/ 16 Ml for Intravenous Use. This tender is published on BelgiumTenders under BET Ref No: 127430734 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-03.

The estimated tender value is EUR 2943059.32, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

BelgiumTenders Features

BelgiumTenders Features

Fresh and verified Tenders from Belgium. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting BelgiumTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Belgium in your email inbox.

  Chat with us